248 related articles for article (PubMed ID: 25378241)
61. F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA).
Nourooz-Zadeh J; Liu EH; Anggård E; Halliwell B
Biochem Biophys Res Commun; 1998 Jan; 242(2):338-44. PubMed ID: 9446796
[TBL] [Abstract][Full Text] [Related]
62. Fatty acids as determinants of in-vivo lipid peroxidation: the EFFGE study in Eastern Finnish hypertensive and non-hypertensive subjects.
Kaikkonen JE; Vilppo T; Asikainen J; Voutilainen S; Kurl S; Salonen JT
Ann Med; 2013 Sep; 45(5-6):455-64. PubMed ID: 23952918
[TBL] [Abstract][Full Text] [Related]
63. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension.
Fessel JP; Porter NA; Moore KP; Sheller JR; Roberts LJ
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16713-8. PubMed ID: 12482927
[TBL] [Abstract][Full Text] [Related]
64. Effects of age and caloric restriction on lipid peroxidation: measurement of oxidative stress by F2-isoprostane levels.
Ward WF; Qi W; Van Remmen H; Zackert WE; Roberts LJ; Richardson A
J Gerontol A Biol Sci Med Sci; 2005 Jul; 60(7):847-51. PubMed ID: 16079206
[TBL] [Abstract][Full Text] [Related]
65. Profiling of oxidized lipid products of marine fish under acute oxidative stress.
Chung ML; Lee KY; Lee CY
Food Chem Toxicol; 2013 Mar; 53():205-13. PubMed ID: 23220612
[TBL] [Abstract][Full Text] [Related]
66. Measurement of chronic oxidative and inflammatory stress by quantification of isoketal/levuglandin gamma-ketoaldehyde protein adducts using liquid chromatography tandem mass spectrometry.
Davies SS; Amarnath V; Brame CJ; Boutaud O; Roberts LJ
Nat Protoc; 2007; 2(9):2079-91. PubMed ID: 17853863
[TBL] [Abstract][Full Text] [Related]
67. The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions.
Mas E; Woodman RJ; Burke V; Puddey IB; Beilin LJ; Durand T; Mori TA
Free Radic Res; 2010 Sep; 44(9):983-90. PubMed ID: 20540666
[TBL] [Abstract][Full Text] [Related]
68. Analytical variables affecting analysis of F2-isoprostanes and F4-neuroprostanes in human cerebrospinal fluid by gas chromatography/mass spectrometry.
Yen HC; Wei HJ; Chen TW
Biomed Res Int; 2013; 2013():810915. PubMed ID: 23957004
[TBL] [Abstract][Full Text] [Related]
69. Special Issue on "Analytical Methods for Oxidized Biomolecules and Antioxidants" The use of isoprostanoids as biomarkers of oxidative damage, and their role in human dietary intervention studies.
Galano JM; Lee YY; Durand T; Lee JC
Free Radic Res; 2015 May; 49(5):583-98. PubMed ID: 25734631
[TBL] [Abstract][Full Text] [Related]
70. Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.
Roberts LJ; Morrow JD
Cell Mol Life Sci; 2002 May; 59(5):808-20. PubMed ID: 12088281
[TBL] [Abstract][Full Text] [Related]
71. F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer's disease.
Nourooz-Zadeh J; Liu EH; Yhlen B; Anggård EE; Halliwell B
J Neurochem; 1999 Feb; 72(2):734-40. PubMed ID: 9930747
[TBL] [Abstract][Full Text] [Related]
72. Identification of lipid derivatives in Hep G2 cells.
Gdula-Argasińska J; Garbacik A; Tyszka-Czochara M; Woźniakiewicz M; Paśko P; Czepiel J
Acta Biochim Pol; 2013; 60(4):811-5. PubMed ID: 24432338
[TBL] [Abstract][Full Text] [Related]
73. Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion.
Mori TA; Puddey IB; Burke V; Croft KD; Dunstan DW; Rivera JH; Beilin LJ
Redox Rep; 2000; 5(1):45-6. PubMed ID: 10905544
[TBL] [Abstract][Full Text] [Related]
74. F2-dihomo-isoprostanes arise from free radical attack on adrenic acid.
VanRollins M; Woltjer RL; Yin H; Morrow JD; Montine TJ
J Lipid Res; 2008 May; 49(5):995-1005. PubMed ID: 18250368
[TBL] [Abstract][Full Text] [Related]
75. A circular toxicity approach to isoprostanes: From markers of oxidative stress, to epidemiological warning systems and agents of aquatic toxicity.
Pais RT; Sousa ACA; Pastorinho MR
Environ Pollut; 2018 Dec; 243(Pt A):654-660. PubMed ID: 30223241
[TBL] [Abstract][Full Text] [Related]
76. The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis.
Miller E; Mrowicka M; Saluk-Juszczak J; Ireneusz M
Neurochem Res; 2011 Jun; 36(6):1012-6. PubMed ID: 21399906
[TBL] [Abstract][Full Text] [Related]
77. Levels of F2-isoprostanes, F4-neuroprostanes, and total nitrate/nitrite in plasma and cerebrospinal fluid of patients with traumatic brain injury.
Yen HC; Chen TW; Yang TC; Wei HJ; Hsu JC; Lin CL
Free Radic Res; 2015; 49(12):1419-30. PubMed ID: 26271312
[TBL] [Abstract][Full Text] [Related]
78. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation.
Morrow JD; Chen Y; Brame CJ; Yang J; Sanchez SC; Xu J; Zackert WE; Awad JA; Roberts LJ
Drug Metab Rev; 1999 Feb; 31(1):117-39. PubMed ID: 10065368
[TBL] [Abstract][Full Text] [Related]
79. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 2: Quantification methods].
Berdeaux O; Scruel O; Durand T; Cracowski JL
Pathol Biol (Paris); 2005 Jul; 53(6):356-63. PubMed ID: 16004948
[TBL] [Abstract][Full Text] [Related]
80. Isoprostanes--markers of ischaemia reperfusion injury.
Sakamoto H; Corcoran TB; Laffey JG; Shorten GD
Eur J Anaesthesiol; 2002 Aug; 19(8):550-9. PubMed ID: 12200943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
